Clean air and containment specialist Envair has announced a new partnership with Dutch engineering firm SmartCompounders. The collaboration means Envair will be the only isolator manufacturer in the UK to offer this innovative solution to personalised medication.
Combining the SmartCompounders Chemo automated solution with the Envair CDC F negative pressure isolator can help pharmacy managers quickly and easily increase output per compounding technician to 20-40 final product containers per hour (IV bags, syringes or elastomeric pumps), improving efficiency and reducing medication errors.
Commenting on the partnership, Envair Managing Director, Gary Bagshaw, said: "With so many clients demanding efficient ways to deliver personalised medicine, we believe the SmartCompounders Chemo integration, which can also connect to prescribing software, is a giant leap forward for hospital pharmacies."
Founder and CEO of SmartCompounders, Sander van Vreeland, added: "With their established relationships with hospitals throughout the UK, we are delighted to be able to add our solution to Envair's portfolio, helping to drive efficiency and improve accuracy in pharmacies and compounding centres."
